oral compounded tirzepatide does not effectively exist. Without a specialized delivery technology like SNAC (under patent by Novo), the drug cannot survive digestion to work in the body. Please beware of scams claiming Oral Tirzepatide: Dual-Incretin GLP-1 in

Hypersensitivity to any component of this product

All research referenced in this article was conducted in animal models or in vitro systems

Prolonged-acting GLP-1 analogs Exenatide LAR or exenatide once weekly is a prolonged-acting GLP-1 analog (median half-life=2 weeks) in which exenatide is incorporated into a 0.06 mm diameter microsphere composed of poly (D,L-lactic-co-glycolic acid) [66]

As such, it's imperative that leaders in the pharmaceutical and market access arenas, not only acknowledge this transformative wave but also proactively shape its trajectory for the benefit of patients and the sustainability of our healthcare systems

That many people particularly those who struggle with eating disorders are abusing GLP-1s doesn't surprise Amanda Banks, a practicing physician who advises multiple biotech and pharmaceutical companies (none involved in GLP-1 production)

doi: 10.1038/nrc2536 76 BachrachLKNanto-SalonenKTapanainenPRosenfeldRGGargoskySE